ADA 2024 Insights
S

Advances in the Pathophysiology & Treatment for Youth-Onset Type 2 Diabetes

By ADA 2024 Insights FEATURING Stephanie Chung
By ADA 2024 Insights FEATURING Stephanie Chung
199 views
August 2, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
47:11
Houston Methodist

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
26:57
Houston Methodist

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Feat. T. R. Mccarty
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
17:21
Ilene Fennoy

Obesity and Diabetes in Children

34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
20:15
Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
21:33
AdventHealth

FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…

Feat. R. Pratley
14:22
Scripps Health

Panel Discussion: Hypertension Management and Coronary Calcium Scori…

Feat. D. Cork, C. Mende, A. Robinson
18:46
Houston Methodist

MAFLD: What Is It?

Feat. D. Victor
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease